68-Ga PSMA11

DRUG3 trials

Sponsors

Andrei Iagaru, University of Texas Southwestern Medical Center

Conditions

Prostate AdenocarcinomaProstate Cancer

Phase 1

68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy

CompletedNCT03949517

Andrei IagaruProstate Cancer

Start: 2019-04-09End: 2022-03-07Updated: 2024-01-30

PSMA PET Response Guided SabR in High Risk Pca

RecruitingNCT06044857

University of Texas Southwestern Medical CenterProstate Adenocarcinoma

Start: 2024-03-07End: 2026-11-01Target: 20Updated: 2026-04-14

Phase 2

HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer

TerminatedNCT04264208

Andrei IagaruProstate Cancer

Start: 2020-02-05End: 2022-12-14Updated: 2024-02-01